Duck Digoxin Immune Fab for Severe Preeclampsia

Digoxin Immune-Fab [(Duck IgY(ΔFc)]: Treatment of Digoxin toxicity and severe preeclampsia. The technology breakthroughs the current production barrier and with the capability to produce millions of vials of anti-Digoxin IgY(ΔFc)-Fab per year.

More information about Digoxin Specific IgY(ΔFc)-Fab.

If you are interested in exploring partnering with us to advance this exciting project, contact us at partnership@good-biotech.com

HOME » News > IgY(ΔFc) derived Digoxin Immune Fab